Delfi Diagnostics is a biotechnology company with a mission to use its technology for early cancer detection. By developing AI and ML algorithms, Delfi Diagnostics offers predictive testing processes with the goal of maximizing patient survival rates.
People also ask
Who is the CEO of Delfi Diagnostics?
When was Delfi Diagnostics founded?
Who is the founder of Delfi?
Who is the CFO of Delfi Diagnostics?
BALTIMORE and PALO ALTO, Calif., July 18, 2022 /PRNewswire/ – Delfi Diagnostics, Inc., a pioneering developer of a new class of high-performance, ...
3 days ago · The capital will accelerate and expand DELFI's development and commercialization of its cancer detection solutions. DELFI's fragmentomics ...
DELFI uses novel machine learning algorithms to analyze fragments of cell-free DNA, resulting in the accurate detection of cancer from a single blood sample.
Jan 27, 2021 · Delfi Diagnostics Raises $100M in Funding Round The liquid biopsy startup plans to use the money to "grow its team of cancer researchers and ...
4 days ago · CHICAGO — Delfi Diagnostics, a company seeking to develop liquid biopsy tests to help screen for lung cancer, published a scientific paper ...
Is Delfi Diagnostics a private or public company? Delfi Diagnostics is a Private company. What is the current valuation of Delfi Diagnostics? The current ...
June 4, 2024. DELFI Diagnostics Announces Equity Investment from the Merck Global Health Innovation Fund to Accelerate DELFI's Cancer Screening AI Fragmentomics ...
Missing: IPO | Show results with:IPO
Delfi Diagnostics Announces $225 Million Series B Financing to ...
www.prnewswire.com › news-releases
Jul 18, 2022 · Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests. USA - English.
Delfi is expanding its team of top talent to help people live longer, healthier, cancer-free lives through widely available, high-performing cancer screening ...
Missing: IPO | Show results with:IPO